Skip to main content

Scott Bilder

Author Biography

Scott Bilder, PhD

Senior Manager, Research Science and Advanced Analytics

Scott is involved in the conceptualization, execution, and delivery of comparative effectiveness, HEOR, performance improvement, and risk adjustment studies that drive opportunity identification and value creation for a diverse array of clients, including health plans, provider networks, patient advocacy groups, and medical societies.

Scott’s experience and interests comprise health services and outcomes research, pharmacoepidemiology, healthcare quality measurement and improvement efforts, and psychometrics in a wide variety of populations, with a particular focus on publicly and privately insured youth and elderly patients.

Before joining Inovalon, Scott was an associate data science and advanced analytics director with IQVIA. Prior to that, he headed the analytic team at the Rutgers University Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes. While at Rutgers he also taught statistics, research design, statistical programming, and psychometric theory and worked as a statistical consultant. In between roles at Rutgers he was a market research and modeling manager at Lucent technologies. Scott holds an AB in psychology from Albright College, an MS in social psychology, and a PhD in educational statistics and measurement (applied statistics and psychometrics) from Rutgers University.

Authored Content

Filter

May 21, 2023
Presentation

Measuring the Value and Return on Investment of Health Insurers Providing Non-Medical Benefits to Support Social Determinants of Health and Other Social Risk Factors

Accepted for presentation at Pharmaceutical Management Science Association (PMSA) 2023 Annual Conference. Findings available upon request. Contact us for more information.
May 7, 2023
Presentation

Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured Before and After Transition to Medicare Advantage or Traditional Medicare Fee-for-Service

Accepted for presentation at ISPOR 2023. Findings available upon request. Contact us for more information.
May 15, 2022
Presentation

Economic Burden of Metastatic Castration Resistant Prostate Cancer, By LINE of Treatment, in Medicare Beneficiaries, 2014-2019

Petrilla A, Robinson, SB, Kumar S, Bilder S, Barrow N, Igboeli P, Hatfield M, Despiegel N, Bhowmik, D, Majd Z, Cai M
This retrospective study describes healthcare resource utilization (HRU) and cost of care, by line of therapy (LOT), in Medicare Fee-for-Service (FFS) beneficiaries diagnosed with mCRPC initiating systemic treatment.
May 15, 2022
Presentation

Economic Burden of Metastatic Castration Resistant Prostate Cancer, By LINE of Treatment, in Medicare Beneficiaries, 2014-2019

Petrilla A, Robinson, SB, Kumar S, Bilder S, Barrow N, Igboeli P, Hatfield M, Despiegel N, Bhowmik, D, Majd Z, Cai M
Accepted for presentation at ISPOR 2022. Findings available upon request. Contact us for more information.
May 15, 2022
Presentation

Identifying Disparities in Health Outcomes and the Relationship to Social Determinants of Health

Accepted for presentation at Pharmaceutical Management Science Association (PMSA) 2022 Annual Conference. Findings available upon request. Contact us for more information.